Efficacy and safety of twice- or thrice-weekly dutasteride versus daily finasteride in men with androgenetic alopecia: A randomized, investigator-blinded, active-controlled, parallel-group pilot study. [PDF]
Sereepanpanich V +3 more
europepmc +1 more source
Th,-e mechanistic insights into the application of retinoids and possible adjunct therapeutic treatment to androgenic alopecia. [PDF]
Irfan H +4 more
europepmc +1 more source
Xiaozhi Yufa decoction ameliorates androgenetic alopecia through inhibition of MAPK signaling and regulation of lipid metabolism. [PDF]
Guo Y +8 more
europepmc +1 more source
Comprehensive Evaluation of <i>Tectona grandis</i> L.f.: Integrated <i>In Vitro</i> and <i>In Silico</i> Analysis of Steroid 5α-Reductase Inhibition and Anti-Inflammatory Properties. [PDF]
Timjan S +6 more
europepmc +1 more source
Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials. [PDF]
Gilbert DC +14 more
europepmc +1 more source
ZBTB7B modulates the androgen receptor as an upstream regulator via colocalization and direct binding in LNCaP prostate cancer cells. [PDF]
Im E +7 more
europepmc +1 more source
<i>Terminalia chebula</i> Retz. Fruit Extract Promotes Murine Hair Growth by Suppressing 5α-Reductase and Accelerating the Degradation of Dihydrotestosterone. [PDF]
Cui T +8 more
europepmc +1 more source
The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients. [PDF]
Jin Q +16 more
europepmc +1 more source
A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia. [PDF]
Panuganti VK +6 more
europepmc +1 more source
Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System. [PDF]
Gupta AK +3 more
europepmc +1 more source

